Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycaemic control in children and adolescents with type 2 diabetes
Phase of Trial: Phase III
Latest Information Update: 02 Jul 2018
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms Ellipse
- Sponsors Novo Nordisk
- 25 May 2018 Status changed from active, no longer recruiting to completed.
- 03 Aug 2017 Planned End Date changed from 29 Jun 2020 to 20 May 2020.
- 10 Jun 2017 Biomarkers information updated